Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63c9137b96e025e14cda72302ca13d65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdcae85f72d638cb6539926a65ee15ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3749c8faaa6cf0e1e7954f4a631ca5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85e1f2b33e36fa602da83a9d1b771ead http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-92 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-573 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2010-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b314a1a24fbc3b209269235023547ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ff55d280f9248efb190de3d5d37635f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16116e2d7e2fee020594e9d4f69feea4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ef16ee1dd84aca84cc8daf891994795 |
publicationDate |
2013-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8372594-B2 |
titleOfInvention |
Secreted phospholipase A2 biomarkers for arthritis |
abstract |
The present invention relates to the use of protein expression profiles of sPLA2 isoforms with clinical relevance to osteoarthritis (OA). In particular, the invention provides methods for diagnosing OA or determining risk factors for development of OA based on expression of sPLA2-IIA. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-025238-B1 |
priorityDate |
2009-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |